Cargando…

Development of MY-DRG casemix pharmacy service weights in UKM Medical Centre in Malaysia

BACKGROUND: The service weight is among several issues and challenges in the implementation of case-mix in developing countries, including Malaysia. The aim of this study is to develop the Malaysian Diagnosis Related Group (MY-DRG) case-mix pharmacy service weight in University Kebangsaan Malaysia-M...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali Jadoo, Saad Ahmed, Aljunid, Syed Mohamed, Nur, Amrizal Muhammad, Ahmed, Zafar, Van Dort, Dexter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337187/
https://www.ncbi.nlm.nih.gov/pubmed/25889668
http://dx.doi.org/10.1186/s40199-014-0075-4
_version_ 1782358578180390912
author Ali Jadoo, Saad Ahmed
Aljunid, Syed Mohamed
Nur, Amrizal Muhammad
Ahmed, Zafar
Van Dort, Dexter
author_facet Ali Jadoo, Saad Ahmed
Aljunid, Syed Mohamed
Nur, Amrizal Muhammad
Ahmed, Zafar
Van Dort, Dexter
author_sort Ali Jadoo, Saad Ahmed
collection PubMed
description BACKGROUND: The service weight is among several issues and challenges in the implementation of case-mix in developing countries, including Malaysia. The aim of this study is to develop the Malaysian Diagnosis Related Group (MY-DRG) case-mix pharmacy service weight in University Kebangsaan Malaysia-Medical Center (UKMMC) by identifying the actual cost of pharmacy services by MY-DRG groups in the hospital. METHODS: All patients admitted to UKMMC in 2011 were recruited in this study. Combination of Step-down and Bottom-up costing methodology has been used in this study. The drug and supplies cost; the cost of staff; the overhead cost; and the equipment cost make up the four components of pharmacy. Direct costing approach has been employed to calculate Drugs and supplies cost from electronic-prescription system; and the inpatient pharmacy staff cost, while the overhead cost and the pharmacy equipments cost have been calculated indirectly from MY-DRG data base. The total pharmacy cost was obtained by summing the four pharmacy components’ cost per each MY-DRG. The Pharmacy service weight of a MY-DRG was estimated by dividing the average pharmacy cost of the investigated MY-DRG on the average of a specified MY-DRG (which usually the average pharmacy cost of all MY-DRGs). RESULTS: Drugs and supplies were the main component (86.0%) of pharmacy cost compared o overhead cost centers (7.3%), staff cost (6.5%) and pharmacy equipments (0.2%) respectively. Out of 789 inpatient MY-DRGs case-mix groups, 450 (57.0%) groups were utilized by the UKMMC. Pharmacy service weight has been calculated for each of these 450 MY-DRGs groups. MY-DRG case-mix group of Lymphoma & Chronic Leukemia group with severity level three (C-4-11-III) has the highest pharmacy service weight of 11.8 equivalents to average pharmacy cost of RM 5383.90. While the MY-DRG case-mix group for Circumcision with severity level one (V-1-15-I) has the lowest pharmacy service weight of 0.04 equivalents to average pharmacy cost of RM 17.83. CONCLUSION: A mixed approach which is based partly on top-down and partly on bottom up costing methodology has been recruited to develop MY-DRG case-mix pharmacy service weight for 450 groups utilized by the UKMMC in 2011.
format Online
Article
Text
id pubmed-4337187
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43371872015-02-24 Development of MY-DRG casemix pharmacy service weights in UKM Medical Centre in Malaysia Ali Jadoo, Saad Ahmed Aljunid, Syed Mohamed Nur, Amrizal Muhammad Ahmed, Zafar Van Dort, Dexter Daru Research Article BACKGROUND: The service weight is among several issues and challenges in the implementation of case-mix in developing countries, including Malaysia. The aim of this study is to develop the Malaysian Diagnosis Related Group (MY-DRG) case-mix pharmacy service weight in University Kebangsaan Malaysia-Medical Center (UKMMC) by identifying the actual cost of pharmacy services by MY-DRG groups in the hospital. METHODS: All patients admitted to UKMMC in 2011 were recruited in this study. Combination of Step-down and Bottom-up costing methodology has been used in this study. The drug and supplies cost; the cost of staff; the overhead cost; and the equipment cost make up the four components of pharmacy. Direct costing approach has been employed to calculate Drugs and supplies cost from electronic-prescription system; and the inpatient pharmacy staff cost, while the overhead cost and the pharmacy equipments cost have been calculated indirectly from MY-DRG data base. The total pharmacy cost was obtained by summing the four pharmacy components’ cost per each MY-DRG. The Pharmacy service weight of a MY-DRG was estimated by dividing the average pharmacy cost of the investigated MY-DRG on the average of a specified MY-DRG (which usually the average pharmacy cost of all MY-DRGs). RESULTS: Drugs and supplies were the main component (86.0%) of pharmacy cost compared o overhead cost centers (7.3%), staff cost (6.5%) and pharmacy equipments (0.2%) respectively. Out of 789 inpatient MY-DRGs case-mix groups, 450 (57.0%) groups were utilized by the UKMMC. Pharmacy service weight has been calculated for each of these 450 MY-DRGs groups. MY-DRG case-mix group of Lymphoma & Chronic Leukemia group with severity level three (C-4-11-III) has the highest pharmacy service weight of 11.8 equivalents to average pharmacy cost of RM 5383.90. While the MY-DRG case-mix group for Circumcision with severity level one (V-1-15-I) has the lowest pharmacy service weight of 0.04 equivalents to average pharmacy cost of RM 17.83. CONCLUSION: A mixed approach which is based partly on top-down and partly on bottom up costing methodology has been recruited to develop MY-DRG case-mix pharmacy service weight for 450 groups utilized by the UKMMC in 2011. BioMed Central 2015-02-10 /pmc/articles/PMC4337187/ /pubmed/25889668 http://dx.doi.org/10.1186/s40199-014-0075-4 Text en © Ali Jadoo et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ali Jadoo, Saad Ahmed
Aljunid, Syed Mohamed
Nur, Amrizal Muhammad
Ahmed, Zafar
Van Dort, Dexter
Development of MY-DRG casemix pharmacy service weights in UKM Medical Centre in Malaysia
title Development of MY-DRG casemix pharmacy service weights in UKM Medical Centre in Malaysia
title_full Development of MY-DRG casemix pharmacy service weights in UKM Medical Centre in Malaysia
title_fullStr Development of MY-DRG casemix pharmacy service weights in UKM Medical Centre in Malaysia
title_full_unstemmed Development of MY-DRG casemix pharmacy service weights in UKM Medical Centre in Malaysia
title_short Development of MY-DRG casemix pharmacy service weights in UKM Medical Centre in Malaysia
title_sort development of my-drg casemix pharmacy service weights in ukm medical centre in malaysia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337187/
https://www.ncbi.nlm.nih.gov/pubmed/25889668
http://dx.doi.org/10.1186/s40199-014-0075-4
work_keys_str_mv AT alijadoosaadahmed developmentofmydrgcasemixpharmacyserviceweightsinukmmedicalcentreinmalaysia
AT aljunidsyedmohamed developmentofmydrgcasemixpharmacyserviceweightsinukmmedicalcentreinmalaysia
AT nuramrizalmuhammad developmentofmydrgcasemixpharmacyserviceweightsinukmmedicalcentreinmalaysia
AT ahmedzafar developmentofmydrgcasemixpharmacyserviceweightsinukmmedicalcentreinmalaysia
AT vandortdexter developmentofmydrgcasemixpharmacyserviceweightsinukmmedicalcentreinmalaysia